Tangent Medical Submits FDA 510(k) for NovaCath Secure IV Catheter System
Tangent Medical, an innovator in IV therapy products, today announced submission of a 510(k) for its NovaCath Secure IV Catheter System, developed from extensive clinical research of healthcare worker and patient needs. This new closed IV catheter system is a next-generation technology designed to address several complex IV therapy challenges including catheter stabilization, occupational exposure to blood, and patient discomfort. When cleared by the FDA, the NovaCath system will be the first safety IV catheter offering advanced catheter stabilization technology...
View full press release